Fung Peter K 4

What Happened Peter K. Fung, a director of Cardio Diagnostics Holdings, Inc. (CDIO), was granted 3,205 derivative shares on March 31, 2026. The reported acquisition price is $1.95 per share, for a total reported value of approximately $6,250. This transaction is coded as an "A" (grant/award/other acquisition) and represents a derivative award rather than an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-31; filing date: 2026-04-02 (appears to be filed timely).
• Instrument/Code: A (Grant/award/other acquisition); described as a derivative acquisition.
• Shares acquired: 3,205 at $1.95 per share; total reported value ≈ $6,250.
• Shares owned after transaction: not disclosed in the provided filing.
• Footnotes/plan info: none provided in the supplied data.

Context An "A" derivative grant typically reflects compensation (e.g., restricted stock units or other derivative awards) rather than a direct purchase on the open market, and the filing does not specify vesting or conversion terms. The amount is modest in dollar value and should be viewed as a compensation-related award unless additional details indicate otherwise.